Prevalence of hepatitis C virus in lymphoproliferative disorders

F Bilwani1, Y Zaidi, G N Kakepoto

  • 1Department of Pathology, The Aga Khan University Hospital, Karachi.

Insights

This study found no significant association between hepatitis C virus infection and lymphoproliferative disorders in the studied population. Further research is needed to confirm any potential causal relationship in this region.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a global health concern.
  • Lymphoproliferative disorders (LPDs) are a group of cancers affecting lymphocytes.
  • The potential link between HCV and LPDs requires further investigation.

Purpose of the Study:

  • To investigate the prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
  • To compare HCV infection rates and risk factors between LPD patients and a control group with non-hematological malignancies.

Main Methods:

  • A prospective case-control study was conducted with 143 LPD patients and 29 controls.
  • Risk factors for HCV infection were assessed.
  • HCV antibody (anti-HCV), cryoglobulins, and rheumatoid factor were tested.
  • HCV RNA was detected using polymerase chain reaction to confirm viremia.

Main Results:

  • No significant difference in HCV risk factors was observed between groups, except for more surgical procedures in controls.
  • Anti-HCV positivity was 5% in LPD patients and 3.4% in controls.
  • HCV RNA was detected in 29.2% of LPD cases and 31.0% of controls.
  • No significant difference in rheumatoid factor or cryoglobulin positivity was found.

Conclusions:

  • The study found no evidence of an association between hepatitis C virus infection and lymphoproliferative disorders in this population.
  • Further regional studies are recommended to explore a potential causal relationship.
Abstract

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...